| LUCAT1 |
|
lung cancer associated transcript 1
|
|
|
0.612 |
0.577 |
| IVL |
P07476
|
involucrin
|
|
|
0.626 |
0.500 |
| MIR576 |
|
microRNA 576
|
|
|
0.686 |
0.385 |
| KIR2DS3 |
Q14952
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 3
|
Receptor
|
|
0.716 |
0.423 |
| FCGR1CP |
|
Fc fragment of IgG receptor Ic, pseudogene
|
|
|
0.769 |
0.462 |
| HBD |
|
hypophosphatemic bone disease
|
|
|
0.780 |
0.269 |
| ADGRE4P |
Q86SQ3
|
adhesion G protein-coupled receptor E4, pseudogene
|
G-protein coupled receptor
|
|
0.780 |
0.231 |
| PADI6 |
Q6TGC4
|
peptidyl arginine deiminase 6
|
|
|
0.760 |
0.269 |
| MIR3196 |
|
microRNA 3196
|
|
|
0.780 |
0.385 |
| LINC00513 |
|
long intergenic non-protein coding RNA 513
|
|
|
0.839 |
0.115 |
| BCC1 |
|
Basal cell carcinoma, susceptibility to, 1
|
|
|
0.890 |
0.115 |
| BCC2 |
|
Basal cell carcinoma, susceptibility to, 2
|
|
|
0.861 |
0.038 |
| MIR5582 |
|
microRNA 5582
|
|
|
0.931 |
0.038 |
| MYCLP1 |
P12525
|
MYCL pseudogene 1
|
Transcription factor
|
|
0.890 |
0.077 |
| BCC4 |
|
Basal cell carcinoma, susceptibility to, 4
|
|
|
1.000 |
0.038 |
| DEFB108A |
A8MXU0
|
defensin beta 108A
|
|
|
1.000 |
0.038 |
| DEFB108C |
A8MXU0
|
defensin beta 108C
|
|
|
1.000 |
0.038 |
| MIB1 |
Q86YT6
|
mindbomb E3 ubiquitin protein ligase 1
|
Enzyme
|
3.4E-88 |
0.438 |
0.769 |
| ROS1 |
P08922
|
ROS proto-oncogene 1, receptor tyrosine kinase
|
Kinase
|
1.6E-72 |
0.439 |
0.885 |
| ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
| NLRP2 |
Q9NX02
|
NLR family pyrin domain containing 2
|
|
1.4E-38 |
0.515 |
0.731 |
| ACE |
P12821
|
angiotensin I converting enzyme
|
Enzyme
|
1.0E-37 |
0.328 |
0.923 |
| RECQL4 |
O94761
|
RecQ like helicase 4
|
Enzyme
|
3.3E-35 |
0.496 |
0.808 |
| TYR |
P14679
|
tyrosinase
|
Enzyme
|
5.0E-32 |
0.473 |
0.808 |
| MSH3 |
P20585
|
mutS homolog 3
|
Nucleic acid binding
|
7.4E-31 |
0.474 |
0.769 |